ACE2 and chronic obstructive pulmonary disease: No difference was found in ACE2 expression in COPD central airways (5.3% ± 2.9) versus smokers without COPD and NS controls (4.7% ± 2.9 and 7.2% ± 3.5, Fig. 1A and Additional file 1: Fig. S1A).